SCHEMBL4437310

SCHEMBL4437310

O=C(O)c1cc(OCc2ccc(Br)cc2Br)ccc1NC(=O)C1CC1.O=C(O)c1cc(OCc2ccc(Cl)cc2Br)ccc1NC(=O)C1CC1

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.48
HSD17B10 Q99714 3/20 0.48
KMT2A Q03164 3/20 0.43
MEN1 O00255 2/20 0.42
ABL1 P00519 1/20 0.40
AKR1C2 P52895 2/20 0.40
AKR1C1 Q04828 2/20 0.40
ALDH1A1 P00352 1/20 0.40
NR4A2 P43354 1/20 0.39
PPARG P37231 1/20 0.39
SERPINE1 P05121 2/20 0.39
FFAR1 O14842 1/20 0.38
S1PR1 P21453 1/20 0.38
LTK P29376 1/20 0.38
TAOK1 Q7L7X3 1/20 0.38
S1PR5 Q9H228 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1823212 0.96 KDM4E (0.52) KDM4EHSD17B10KMT2AABL1ALDH1A1
SCHEMBL1825095 0.94 KDM4E (0.54) KDM4EHSD17B10KMT2AMEN1ABL1
SCHEMBL4437313 0.92 KMT2A (0.43) KDM4EHSD17B10KMT2AMEN1ABL1
SCHEMBL1824677 0.88 KDM4E (0.52) KDM4EHSD17B10KMT2AMEN1ABL1
SCHEMBL1825586 0.86 NR4A2 (0.55) KDM4EHSD17B10KMT2AMEN1ALDH1A1
SCHEMBL1823309 0.84 KDM4E (0.52) KDM4EHSD17B10KMT2AMEN1ABL1
SCHEMBL1823741 0.84 KMT2A (0.58) KDM4EHSD17B10KMT2AALDH1A1NR4A2
SCHEMBL1826208 0.84 KDM4E (0.52) KDM4EHSD17B10KMT2AMEN1ABL1
SCHEMBL1825548 0.82 KDM4E (0.54) KDM4EHSD17B10KMT2AMEN1ALDH1A1
SCHEMBL1825885 0.82 KDM4E (0.49) KDM4EHSD17B10KMT2AABL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2118051-A1 NEW COMPOUNDS, METHODS FOR THEIR PREPARATION AND USE THEREOF Chelsea Therapeutics, Inc. (US) 2009-11-18 EP disclosed
WO-2008097180-A1 NEW COMPOUNDS, METHODS FOR THEIR PREPARATION AND USE THEREOF CHELSEA THERAPEUTICS, INC. (US) 2008-08-14 WO disclosed